Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 12 2020 000 038.8 |
| Use | VZ | Medicinal products |
| 95 | Product name | TIEZ | Crisaborol, gegebenenfalls in Form eines pharmazeutisch annehmbaren Salzes davon |
| 54 | Title of basic patent | TIGZ | Biozide Boronophthalidverbindungen |
| 51 | IPC main class | ICM (ICMV) | C07F 5/02 (2006.01) |
| 51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/69 (2006.01), A61P 31/10 (2006.01) |
| 94 | Start of term of protection | LB | Feb 17, 2026 |
| 94 | End of term of protection | LE | Feb 16, 2031 |
| 22 | DE application date | DAT | Jul 22, 2020 |
| Date of publication of application for a certificate | OT | Oct 29, 2020 |
| Date of publication of grant of certificate | PET | May 19, 2022 |
| 71/73 | Applicant/owner | INH | Anacor Pharmaceuticals, LLC (n.d.Ges.d. Staates Delaware), New York, NY, US |
| 74 | Representative | VTR | Kraus & Lederer PartGmbB, 80539 München, DE |
| Address for service | | Kraus & Lederer PartGmbB, 80539 München, DE |
| Due date | FT FG | Feb 28, 2026 Annual fee for the 21st year
Patent fees |
| Patent division in charge | | 44 |
| 68 | DE file number of basic patent | GAKZ | 60 2006 045 680.8 |
| 68 | EP file number of basic patent | GEAKZ | 11 15 4575.2 |
| 43 | Date of first publication | EVT | Oct 29, 2020 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/19/1421 2020-03-27
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/19/1421 2020-03-27
|
| Date of the first transfer into DPMAregister | EREGT | Oct 29, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 24, 2024 (Show all update days)(Hide all update days)- Jul 24, 2024
- St.36: changed (technical change)
- Jan 2, 2024; Dec 22, 2023; Jul 13, 2023; Apr 30, 2022; Apr 15, 2022; Feb 11, 2022
- Historical data not available for this/these date(s)
- Oct 29, 2020
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 4)| INID | Criterion | Field | Content
Close details
|
|---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 12, 2023 |
| 71/73 | Applicant/owner | INH | Anacor Pharmaceuticals, LLC (n.d.Ges.d. Staates Delaware), New York, NY, US |
| 71/73 | Previous applicant/owner | INHF | Anacor Pharmaceuticals, Inc., New York, NY, US |
| Date of update of the procedure | REGT | Jul 13, 2023 |